Fig. 2

PASI score and CRP levels in psoriatic patients on the basis of MUFA intake. Psoriatic patients were divided in two groups on the basis of median percentage of MUFA intake (18.2 %). Patients with MUFA intake below median (Low-MUFA) presented higher values of PASI score and CRP levels when compared with patients having a MUFA intake higher than the median (High-MUFA). PASI Psoriasis Area and Severity Index, CRP C-reactive protein